Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axcella Health Inc. | Director | Common Stock | 210K | $122K | $0.58 | May 19, 2022 | Direct |
Evelo Biosciences, Inc. | Director | Common Stock | 93.9K | $31K | $0.33 | Jun 30, 2022 | Direct |
Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 500K | May 12, 2022 | Direct | ||
Senti Biosciences, Inc. | Director | Stock Option (Right to Buy) | 125K | Jul 13, 2022 | Direct | ||
Tempus AI, Inc. | Director | Class A Common Stock | 28.5K | Jun 13, 2024 | Direct | ||
Evelo Biosciences, Inc. | Director | Restricted Stock Units | 0 | Jun 30, 2022 | Direct | ||
Opy Acquisition Corp. I | Director | Common Stock | 0 | Oct 26, 2021 | Direct | ||
Seagen Inc. | CEO, Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | CEO, Director | Performance Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | CEO, Director | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | CEO, Director | Stock Options (Right to Buy) | 0 | Dec 14, 2023 | Direct |